Homocysteine and brain atrophy on MRI of non-demented elderly - Wikidata - awgldk - TriplyDB

Homocysteine and brain atrophy on MRI of non-demented elderly

Homocysteine and brain atrophy on MRI of non-demented elderly

http://www.wikidata.org/entity/Q57782041

about

Homocysteine and cognitive impairment; a case series in a General Practice setting Albumin and multiple sclerosis Homocysteine, folate and vitamin B12 in neuropsychiatric diseases: review and treatment recommendations Neuroenhancement with vitamin B12-underestimated neurological significance Brain imaging and human nutrition: which measures to use in intervention studies?Emerging roles for folate and related B-vitamins in brain health across the lifecycle.MR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders.Methodology for measuring cerebrovascular disease burden.Association between Homocysteine Levels and All-cause Mortality: A Dose-Response Meta-Analysis of Prospective Studies.Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis Homocysteine, grey matter and cognitive function in adults with cardiovascular disease Homocysteine levels in schizophrenia and affective disorders-focus on cognition.Cardiovascular risk factors and future risk of Alzheimer's disease.Volume of the hippocampal subfields in healthy adults: differential associations with age and a pro-inflammatory genetic variant.Status of vitamins B-12 and B-6 but not of folate, homocysteine, and the methylenetetrahydrofolate reductase C677T polymorphism are associated with impaired cognition and depression in adults Genetic Influences on Plasma Homocysteine Levels in African Americans and Yoruba Nigerians Plasma homocysteine, Alzheimer and cerebrovascular pathology: a population-based autopsy study.The worldwide challenge of the dementias: a role for B vitamins and homocysteine?Folate and Vitamin B12-Related Biomarkers in Relation to Brain Volumes Modifiable factors that alter the size of the hippocampus with ageing.Lowering homocysteine levels with folic acid and B-vitamins do not reduce early atherosclerosis, but could interfere with cognitive decline and Alzheimer's disease.The long-term safety of antiepileptic drugs."Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.Correlations between homocysteine and grey matter volume in patients with Alzheimer's disease.Increased Total Homocysteine Levels Predict the Risk of Incident Dementia Independent of Cerebral Small-Vessel Diseases and Vascular Risk Factors.Marked cerebral atrophy is correlated with kidney dysfunction in nondisabled adults.Homocysteine is associated with hippocampal and white matter atrophy in older subjects with mild hypertension.Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia.Hippocampal shape is predictive for the development of dementia in a normal, elderly population.B-vitamins and prevention of dementia.Effects of folic acid supplementation on cognitive function and Aβ-related biomarkers in mild cognitive impairment: a randomized controlled trail.Cross-Sectional Associations of Total Plasma Homocysteine with Cortical β-Amyloid Independently and as a Function of Omega 3 Polyunsaturated Fatty Acid Status in Older Adults at Risk of Dementia.Synergistic Toxicity of the Neurometabolites Quinolinic Acid and Homocysteine in Cortical Neurons and Astrocytes: Implications in Alzheimer's Disease.Correlations between folate, B12, homocysteine levels, and radiological markers of neuropathology in elderly post-stroke patients.Anticonvulsive effect of folic acid in homocysteine thiolactone-induced seizures.Mouse model for deficiency of methionine synthase reductase exhibits short-term memory impairment and disturbances in brain choline metabolism.Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints.Biological determinants of postural disorders in elderly women.Mild cognitive impairment, risk factors and magnetic resonance volumetry: role of probable Alzheimer's disease in the family.Memory improvements in elderly women following 16 weeks treatment with a combined multivitamin, mineral and herbal supplement: A randomized controlled trial.

P2860

Q25257672-19434227-8998-434D-8B69-A19253B510E7 Q26749307-30D4B4BD-605F-451D-B5D8-4C999A8B59E1 Q28259237-F57DD698-EFF4-4CA8-839C-60E43D2F6A08 Q28304338-B8401935-4FA9-4978-9361-FB7A7DE10AF6 Q30658391-42DAFAC7-4FD1-4821-B76C-5FFD40092F71 Q30867600-5D21DB0B-FEC7-4EEA-8A08-CAD5342A9A90 Q30957247-66EEB881-EB14-407B-8B14-067F0F2AFE57 Q31073697-7CE19904-44CC-46D5-BC62-EC48690FC66B Q33881431-CFBECD9D-12E0-4D68-BA1C-B614BB0A5071 Q33904779-A7344CA6-4A4B-405C-AF2E-1D20E38F3EF3 Q34193816-6D72FC3C-CC8E-422C-BD60-E7EA386C705E Q34292122-4F4EEFB7-CBA8-49ED-A326-A243E4B86B02 Q34484531-6AE28C6C-A25A-4BB9-A674-856AAD8F19C5 Q34747395-B6356A98-B0BE-41F4-8AD3-387C56062D81 Q36096343-8261265F-755D-4DD7-9EAC-184A381913FD Q36770198-E51928CE-DAC9-4016-80BB-1CA1033FBAAE Q37124508-2F2EC893-6897-4C0A-895F-7CB8F45B580E Q37246161-954ABCB8-F227-48E2-8A06-5823D18A340F Q37628312-3FFF1A7F-83D7-4A68-B0DA-8FEAD3128747 Q37992811-AFEC9420-A5D4-4A9E-8C94-B37C1732E5E6 Q38066028-E7089C3F-F1E4-4810-89F7-C445E2CD2265 Q38106856-F0CA48DE-58F7-4B87-83EF-7E08DCEBADFB Q38441500-0D23A499-8FA2-4E3F-A3E8-76670F79EA1F Q39064336-8F3856F0-B253-45E9-995A-E4D70B746FA2 Q41199801-707E4655-1847-4D46-B79B-CDB0BE00A286 Q42859671-C5C4B24B-AC7E-4276-AE86-C3E7CAD7D54B Q43107052-30264822-7D99-4855-8296-D6FC1E584C1A Q44576863-D495508E-549A-480F-B399-4DEC9130D318 Q46053385-E1F5063A-C23C-4213-9E8A-52EEFA8362E5 Q46782925-F02CA7B5-B5AF-4E7B-B409-26CA74C80FAF Q47285255-23B03BE7-B3E3-445A-AAFE-4F0D9ED4D521 Q47393332-8D390329-306E-4326-A3F0-15144811BD66 Q47417741-502D3C10-38A4-4253-B0D0-B533C9727123 Q48103362-1CC5E79E-21FA-429D-AF4C-B0DF0360E606 Q48253374-37F093FD-9370-44CD-BC4F-97D1228BC7D2 Q48790868-6F879B85-64C0-456C-853D-36F329F99F1D Q48829714-D5FA7B59-7614-422E-AE53-18ECE4083A44 Q50745798-DFF21E99-93CF-490F-BE18-EFD7019F3152 Q50881899-749CAD04-90A1-4903-8458-58DCA1B67234 Q50987345-4D7C4E0E-27BC-4552-8BD3-F503FE52728C

P2860

Homocysteine and brain atrophy on MRI of non-demented elderly

http://www.wikidata.org/entity/Q57782041

description

im Januar 2003 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в січні 2003

@uk

name

Homocysteine and brain atrophy on MRI of non-demented elderly

@en

Homocysteine and brain atrophy on MRI of non-demented elderly

@nl

type

label

Homocysteine and brain atrophy on MRI of non-demented elderly

@en

Homocysteine and brain atrophy on MRI of non-demented elderly

@nl

prefLabel

Homocysteine and brain atrophy on MRI of non-demented elderly

@en

Homocysteine and brain atrophy on MRI of non-demented elderly

@nl

P1433

Q57782041-6B372151-B52D-4708-9957-98D778A0BA71

P1476

Q57782041-499B449D-205F-45BD-85CF-0F7FE4CF4490

P2093

Q57782041-4888005F-571F-402B-BB03-5660FCBF5F3F

Q57782041-68E09ECE-EC61-4E67-9E8A-AFA0F3853C1B

Q57782041-7CF4567D-3FB7-4848-B098-F3B6EA5A9A1E

Q57782041-8145FE00-C5E8-4A1B-AE8C-B42AF8EEA10F

Q57782041-8BC67B90-D875-413B-B130-ECC62DA1211E

Q57782041-A33C271F-60BC-45BA-9B0B-3094ABFA8F01

Q57782041-EA6FB10E-40F2-46DF-92EA-C0BD989ED63F

P2860

Q57782041-073D3B7D-58EF-4792-818E-B01DC06E8C7E

Q57782041-0F1E4147-0909-40A6-BFEF-92DC744E52B9

Q57782041-181913D7-A652-451C-BAD3-26C17B1B31AB

Q57782041-18ADC991-D1F1-42B6-9615-85B18E045996

Q57782041-1935772D-74B0-4B13-B29C-747F251FBB63

Q57782041-205BA6B9-7C1F-49BD-A00A-A15848C5FB67

Q57782041-27CE78F3-280F-43FB-96E4-9747D5E1D120

Q57782041-2F83CA30-2934-43AE-A2B8-DF175673FDF7

Q57782041-34632852-8B98-4B06-AB00-FCEB023FF75B

Q57782041-48894780-7F7D-400E-AF1C-B6575238512C

P304

Q57782041-6F5B000D-D0E6-4CAA-8CA9-11593D6CBE49

P31

Q57782041-57357273-CA9F-4659-9CD8-60E1AC6C7DBD

P356

Q57782041-1059208B-01E6-4266-B0FD-BE6C40E8336B

P407

Q57782041-E5616B18-AD4B-4334-BD41-FF5C61271B73

P433

Q57782041-83DAB99A-A520-4C67-AB2B-01C03C1DB1F7

P478

Q57782041-3D6A211D-EF9C-4AEE-9416-1E05D12C3711

P577

Q57782041-162EB0BC-1F62-4377-A0B2-B9CB5D428F43

P356

P1433

P1476

Homocysteine and brain atrophy on MRI of non-demented elderly

@en

P2093

A. Hofman

http://www.w3.org/2001/XMLSchema#string

M. M. B. Breteler

http://www.w3.org/2001/XMLSchema#string

M. Oudkerk

http://www.w3.org/2001/XMLSchema#string

P. J. Koudstaal

http://www.w3.org/2001/XMLSchema#string

R. Clarke

http://www.w3.org/2001/XMLSchema#string

S. E. Vermeer

http://www.w3.org/2001/XMLSchema#string

T. den Heijer

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence and Risk Factors of Silent Brain Infarcts in the Population-Based Rotterdam Scan Study

Homocysteine and cardiovascular disease

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.

Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study.

Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor.

Rates of hippocampal atrophy correlate with change in clinical status in aging and AD.

Total serum homocysteine in senile dementia of Alzheimer type.

Determinants of disease and disability in the elderly: the Rotterdam Elderly Study.

Cerebral white matter lesions and atherosclerosis in the Rotterdam Study.

Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins.

P304

170-175

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWG006

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

126

http://www.w3.org/2001/XMLSchema#string

P577

2003-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime